Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - Loss AllowanceNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Raw Materials: 2018-2024

Historic Raw Materials for RedHill Biopharma (RDHL) over the last 7 years, with Dec 2024 value amounting to $513,000.

  • RedHill Biopharma's Raw Materials fell 38.04% to $513,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $513,000, marking a year-over-year decrease of 38.04%. This contributed to the annual value of $513,000 for FY2024, which is 38.04% down from last year.
  • According to the latest figures from FY2024, RedHill Biopharma's Raw Materials is $513,000, which was down 38.04% from $828,000 recorded in FY2023.
  • RedHill Biopharma's 5-year Raw Materials high stood at $3.0 million for FY2021, and its period low was $513,000 during FY2024.
  • Its 3-year average for Raw Materials is $1.0 million, with a median of $828,000 in 2023.
  • Per our database at Business Quant, RedHill Biopharma's Raw Materials surged by 68.08% in 2021 and then slumped by 53.92% in 2023.
  • RedHill Biopharma's Raw Materials (Yearly) stood at $1.8 million in 2020, then soared by 68.08% to $3.0 million in 2021, then crashed by 40.34% to $1.8 million in 2022, then crashed by 53.92% to $828,000 in 2023, then tumbled by 38.04% to $513,000 in 2024.